Literature DB >> 18636761

The binding orientation of a norindenoisoquinoline in the topoisomerase I-DNA cleavage complex is primarily governed by pi-pi stacking interactions.

Yunlong Song1, Mark Cushman.   

Abstract

High level ab initio quantum chemical studies have shown that the binding orientations of topoisomerase I (top1) inhibitors such as camptothecins and indenoisoquinolines are primarily governed by pi-pi stacking. However, a recently discovered norindenoisoquinoline antitumor compound was observed by X-ray crystallography to adopt a "flipped" orientation (relative to indenoisoquinolines), which facilitates the formation of a characteristic hydrogen bond with the Arg364 of top1 in its binding with the top1-DNA complex. This observation raises the possibility that hydrogen bonding between the norindenoisoquinoline nitrogen and the Arg364 side chain of top1 might be responsible for the "flip". It also brings into question whether pi-pi stacking, as opposed to hydrogen bonding, is primarily responsible for the binding orientations of indenoisoquinolines and norindenoisoquinolines. In this study, the forces responsible for the binding orientation of a norindenoisoquinoline in the DNA cleavage site were systematically investigated using MP2 methods. The theoretical calculation of the preferred binding orientation based solely on pi-pi stacking was completely consistent with the actual orientation observed by X-ray crystallography, indicating that the binding of the norindenoisoquinoline in the top1-DNA complex is mainly governed by pi-pi stacking forces and that the "flip" can occur independently from hydrogen bonding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636761      PMCID: PMC2538616          DOI: 10.1021/jp8005603

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  20 in total

1.  Olefinic vs. aromatic pi-H interaction: a theoretical investigation of the nature of interaction of first-row hydrides with ethene and benzene.

Authors:  P Tarakeshwar; H S Choi; K S Kim
Journal:  J Am Chem Soc       Date:  2001-04-11       Impact factor: 15.419

2.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

3.  Binding of cationic and neutral phenanthridine intercalators to a DNA oligomer is controlled by dispersion energy: quantum chemical calculations and molecular mechanics simulations.

Authors:  Tomás Kubar; Michal Hanus; Filip Ryjácek; Pavel Hobza
Journal:  Chemistry       Date:  2005-12-16       Impact factor: 5.236

4.  Toward true DNA base-stacking energies: MP2, CCSD(T), and complete basis set calculations.

Authors:  Pavel Hobza; Jirí Sponer
Journal:  J Am Chem Soc       Date:  2002-10-02       Impact factor: 15.419

5.  An ab initio quantum mechanics calculation that correlates with ligand orientation and DNA cleavage site selectivity in camptothecin-DNA-topoisomerase I ternary cleavage complexes.

Authors:  Xiangshu Xiao; Mark Cushman
Journal:  J Am Chem Soc       Date:  2005-07-20       Impact factor: 15.419

6.  Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.

Authors:  Bart L Staker; Michael D Feese; Mark Cushman; Yves Pommier; David Zembower; Lance Stewart; Alex B Burgin
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

7.  On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.

Authors:  Xiangshu Xiao; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

Review 8.  Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.

Authors:  Yves Pommier; Jacqueline Cherfils
Journal:  Trends Pharmacol Sci       Date:  2005-03       Impact factor: 14.819

9.  Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison.

Authors:  G Kohlhagen; K D Paull; M Cushman; P Nagafuji; Y Pommier
Journal:  Mol Pharmacol       Date:  1998-07       Impact factor: 4.436

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  11 in total

1.  7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.

Authors:  Evgeny Kiselev; Sean DeGuire; Andrew Morrell; Keli Agama; Thomas S Dexheimer; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2011-08-08       Impact factor: 7.446

2.  Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.

Authors:  Katherine E Peterson; Maris A Cinelli; Andrew E Morrell; Akhil Mehta; Thomas S Dexheimer; Keli Agama; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

3.  Computational model for predicting experimental RNA and DNA nearest-neighbor free energy rankings.

Authors:  Charles A Johnson; Richard J Bloomingdale; Vikram E Ponnusamy; Conor A Tillinghast; Brent M Znosko; Michael Lewis
Journal:  J Phys Chem B       Date:  2011-06-30       Impact factor: 2.991

4.  Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.

Authors:  Yunlong Song; Zhiyu Shao; Thomas S Dexheimer; Evan S Scher; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

5.  Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.

Authors:  Evgeny Kiselev; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

6.  The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives.

Authors:  Yves Pommier; Mark Cushman
Journal:  Mol Cancer Ther       Date:  2009-04-21       Impact factor: 6.261

7.  Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

Authors:  Daniel E Beck; P V Narasimha Reddy; Wei Lv; Monica Abdelmalak; Gabrielle S Tender; Sophia Lopez; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2016-04-12       Impact factor: 7.446

8.  Fabrication and Molecular Modeling of Navette-Shaped Fullerene Nanorods Using Tobacco Mosaic Virus as a Nanotemplate.

Authors:  Çiğdem Dönmez Güngüneş; Sinan Başçeken; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Mol Biotechnol       Date:  2022-01-24       Impact factor: 2.695

9.  Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.

Authors:  Malgorzata N Drwal; Keli Agama; Laurence P G Wakelin; Yves Pommier; Renate Griffith
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  Solvent dependency of the UV-Vis spectrum of indenoisoquinolines: role of keto-oxygens as polarity interaction probes.

Authors:  Andrea Coletta; Silvia Castelli; Giovanni Chillemi; Nico Sanna; Mark Cushman; Yves Pommier; Alessandro Desideri
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.